Biodesix, Inc. (BDSX)
8.94
+1.06
(+13.45%)
USD |
NASDAQ |
Jan 20, 16:00
9.05
+0.11
(+1.23%)
After-Hours: 18:06
Biodesix EPS Diluted (Quarterly): -1.162 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 4.275 |
| FONAR Corp. | 0.3368 |
| XWELL, Inc. | -0.2557 |
| ProPhase Labs, Inc. | -1.646 |
| Veracyte, Inc. | 0.2401 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.716M |
| Revenue (Quarterly) | 21.77M |
| Total Expenses (Quarterly) | 30.48M |
| Enterprise Value | 119.26M |
| Gross Profit Margin (Quarterly) | 81.14% |
| Profit Margin (Quarterly) | -40.04% |
| Earnings Yield | -43.93% |
| Normalized Earnings Yield | -43.83 |